Financial comparisons Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.880 USD | -1.57% |
|
-6.39% | -49.82% |
| Nov. 26 | Sector Update: Health Care Stocks Edge Higher Premarket Wednesday | MT |
| Nov. 25 | Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 838M | -15.2% | 2.6% | 1.68% | 1.15% | -1.55x | |
| 4.12B | 10.85% | 15.45% | 10.86% | 7.83% | 0.04x | |
| 739M | -59.05% | -60.02% | -1,123.05% | -26.67% | -0.76x | |
| 621M | 40.32% | 46.55% | 22.85% | 20.5% | -0.42x | |
| 1.53B | 20.37% | 41.94% | 32.82% | - | -0.49x | |
| 1.23B | 15.78% | 25.57% | 11.2% | 5.74% | 1.57x | |
| 613M | 26.71% | 27.86% | 13.92% | 10.2% | - | |
| 355M | 64.38% | - | - | - | - | |
| 69.99M | -35.08% | -33.66% | -5.7% | -5.21% | - | |
| 611M | -29.9% | -31.85% | -25.17% | -19.39% | 2.48x | |
| 326M | 14.24% | 21.7% | 3.9% | 3.04% | 0.78x | |
| 217M | 6.33% | 8.56% | 2.77% | 1.88% | - | |
| 200M | 18.9% | 19.05% | 3.7% | 3.23% | - | |
| 420M | 18.33% | 20.78% | 10.88% | 8.69% | - | |
| 1.14B | 0.67% | 4.26% | 1.29% | 0.39% | - | |
| 152M | 22.98% | 26.42% | 14.37% | 11.66% | -2.37x | |
| 332M | 5.49% | 2.61% | 4.31% | 3.71% | - | |
| 227M | 32.11% | 37.62% | 13.64% | 9.91% | - | |
| Average | 763M | 8.79% | 10.32% | -59.16% | 2.29% | -0.08x | |
| Weighted average by Cap. | 1.49B | 1.09% | 3.02% | -226.45% | -0.6% | -0.10x |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
